{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:43:59Z","timestamp":1775587439902,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jconrel.2020.02.025","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:11:15Z","timestamp":1581538275000},"page":"222-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-1212","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4981","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.02.025_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2019.01.011","article-title":"Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies","volume":"296","author":"Ghosh","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0020","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acs.nanolett.8b03043","article-title":"Green mass production of pure nanodrugs via an ice-template-assisted strategy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0030","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1021\/jacs.8b04556","article-title":"Nucleoside analogue-based supramolecular nanodrugs driven by molecular recognition for synergistic cancer therapy","volume":"140","author":"Wang","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/nl503598u","article-title":"Preparation and size control of sub-100 nm pure nanodrugs","volume":"15","author":"Zhang","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0040","doi-asserted-by":"crossref","first-page":"19295","DOI":"10.1021\/acsami.5b05347","article-title":"Nanodrug formed by coassembly of dual anticancer drugs to inhibit cancer cell drug resistance","volume":"7","author":"Zhao","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.addr.2007.11.007","article-title":"Clinical toxicities of nanocarrier systems","volume":"60","author":"Vega-Villa","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.biomaterials.2016.10.016","article-title":"Drug self-delivery systems for cancer therapy","volume":"112","author":"Qin","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0055","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1021\/ja505212y","article-title":"Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy","volume":"136","author":"Huang","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the epr effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0065","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1002\/adma.201601498","article-title":"Hierarchical targeting strategy for enhanced tumor tissue accumulation\/retention and cellular internalization","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0070","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/acsnano.9b05425","article-title":"Tumor microenvironment responsive shape-reversal self-targeting virus-inspired nanodrug for imaging-guided near-infrared-ii photothermal chemotherapy","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0075","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nnano.2014.208","article-title":"Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy","volume":"9","author":"Chung","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0080","doi-asserted-by":"crossref","first-page":"13386","DOI":"10.1021\/ja304239g","article-title":"Specific cell surface protein imaging by extended self-assembling fluorescent turn-on nanoprobes","volume":"134","author":"Mizusawa","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.132.1.35","article-title":"Endocytosis of gpi-linked membrane folate receptor-alpha","volume":"132","author":"Rijnboutt","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"C. International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase i inhibitors: Camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/286309a0","article-title":"Methotrexate binding to dihydrofolate reductase","volume":"286","author":"Roberts","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jconrel.2017.09.007","article-title":"Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy","volume":"266","author":"Xu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0110","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nano.2015.12.373","article-title":"In vitro and in vivo anti-tumor efficacy of 10-hydroxycamptothecin polymorphic nanoparticle dispersions: shape- and polymorph-dependent cytotoxicity and delivery of 10-hydroxycamptothecin to cancer cells","volume":"12","author":"Wang","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0115","doi-asserted-by":"crossref","first-page":"14347","DOI":"10.1039\/C7NR03129G","article-title":"Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo","volume":"9","author":"Wen","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1039\/c3fd00099k","article-title":"Self-assembly of natural and synthetic drug amphiphiles into discrete supramolecular nanostructures","volume":"166","author":"Lock","year":"2013","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0125","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1039\/C4CP00367E","article-title":"Supramolecular gel from folic acid with multiple responsiveness, rapid self-recovery and orthogonal self-assemblies","volume":"16","author":"Xing","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0130","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1021\/acsnano.8b03529","article-title":"Self-assembled minimalist multifunctional theranostic nanoplatform for magnetic resonance imaging-guided tumor photodynamic therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0135","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1021\/acs.chemrev.5b00583","article-title":"Experimental binding energies in supramolecular complexes","volume":"116","author":"Biedermann","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2017.05.011","article-title":"Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy","volume":"258","author":"Li","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0145","doi-asserted-by":"crossref","first-page":"34650","DOI":"10.1021\/acsami.7b10027","article-title":"Methotrexate-camptothecin prodrug nanoassemblies as a versatile nanoplatform for biomodal imaging-guided self-active targeted and synergistic chemotherapy","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1039\/B919678C","article-title":"Supramolecular amphiphiles","volume":"40","author":"Zhang","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0155","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1021\/la900734d","article-title":"Supramolecular assemblies of amphiphilic homopolymers","volume":"25","author":"Kale","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2010.06.019","article-title":"Post-insertion into lipid nanocapsules (lncs): from experimental aspects to mechanisms","volume":"396","author":"Perrier","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0165","doi-asserted-by":"crossref","first-page":"1703135","DOI":"10.1002\/adma.201703135","article-title":"Self-assembly of an amphiphilic janus camptothecin-floxuridine conjugate into liposome-like nanocapsules for more efficacious combination chemotherapy in cancer","volume":"29","author":"Liang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2017.03.391","article-title":"Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma","volume":"254","author":"Pei","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0175","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/anie.201509810","article-title":"Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy","volume":"55","author":"Liu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2015.10.031","article-title":"Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy","volume":"220","author":"Hu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0190","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1021\/acsami.6b02416","article-title":"Carrier-free, chemophotodynamic dual nanodrugs via self-assembly for synergistic antitumor therapy","volume":"8","author":"Zhang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0195","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1007\/s12274-018-2014-z","article-title":"Convenient preparation of charge-adaptive chitosan nanomedicines for extended blood circulation and accelerated endosomal escape","volume":"11","author":"Zhang","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0205","first-page":"1902604","article-title":"Ligand-installed nanocarriers toward precision therapy","author":"Mi","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","article-title":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","volume":"293","author":"Shi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2016.06.021","article-title":"Dual cd44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery","volume":"236","author":"Lee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.025_bb0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/cb700248m","article-title":"Bright ideas for chemical biology","volume":"3","author":"Lavis","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0225","first-page":"3396","article-title":"Distribution of the folate receptor gp38 in normal and malignant cell lines and tissues","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.02.025_bb0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:47:48Z","timestamp":1759160868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":46,"alternative-id":["S0168365920301152"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}